Loading
Latest filing published 27 May 2021 for Aditx Therapeutics, Inc.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
One trade, one date: on 27 May 2021, Thomas J. Farley disclosed an open-market purchase of €5,495 in Aditxt, Inc. No broader history exists yet. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration